Protective Effects and Mechanisms of Luteolin against Acute Respiratory Distress Syndrome: Network Pharmacology and In vivo and In vitro Studies

Quan Li,Juan Chen,Yi Ren,Zhizhou Yang,Mengmeng Wang,Wei Zhang,Liping Cao,Haijun Sun,Shinan Nie,Zhaorui Sun
DOI: https://doi.org/10.2174/0113816128289341240327072531
IF: 3.31
2024-04-15
Current Pharmaceutical Design
Abstract:CONCLUSION: Luteolin could reduce the production of reactive oxygen species and inflammatory factors by inhibiting the AKT/NF-κB signaling pathway, thus reducing apoptosis and attenuating ARDS.
pharmacology & pharmacy
What problem does this paper attempt to address?